In vitro inhibition of natural-killer-mediated lysis by chromatin fragments
- PMID: 7923249
- PMCID: PMC11038104
- DOI: 10.1007/BF01533385
In vitro inhibition of natural-killer-mediated lysis by chromatin fragments
Abstract
A qualitative impairment of natural killer (NK) function and the presence of circulating DNA have been independently reported in clinical situations such as cancer and lupus. The existence of receptors for chromatin fragments at the leukocyte membrane raised the question of the relation between the presence of chromatin fragments in the extracellular medium and the impairment of NK function. The present study shows that plasmas from patients with metastatic cancer and with pathological DNA concentrations inhibited significantly the NK activity of normal lymphocytes as compared to cancer plasmas with DNA concentrations in the normal range. In vitro, it was demonstrated that chromatin fragments inhibited the NK-mediated cytotoxicity in a dose-dependent manner. Inhibitory concentrations of nucleosomes (2.5-10 micrograms/ml) were lower than those of DNA and histones alone (100 micrograms/ml). Inhibitory effects of nucleosomes, DNA and histones differed also according to the effector population used: nucleosomes were effective whatever the CD56+ cell enrichment of the effector population, while DNA inhibition needed T cells, and histone inhibition probably resulted from a subtoxic effect, prevented by the presence of adherent cells. Finally we found that nucleosomes could inhibit the NK function only when they were present in the extracellular medium. Taken together, these data suggest that the persistence of nucleosomal DNA at sites of cell death or in the blood might be responsible, at least partly, for the NK activity impairment observed in pathological circumstances characterized by a high rate of cell death phenomena such as cancer.
Similar articles
-
Nucleosome-dependent escape of tumor cells from natural-killer-mediated lysis: nucleosomes are taken up by target cells and act at a postconjugation level.Cancer Immunol Immunother. 1997 Jan;43(6):337-44. doi: 10.1007/s002620050342. Cancer Immunol Immunother. 1997. PMID: 9067405 Free PMC article.
-
Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus.Front Immunol. 2021 May 3;12:633658. doi: 10.3389/fimmu.2021.633658. eCollection 2021. Front Immunol. 2021. PMID: 34012432 Free PMC article.
-
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines.J Neuroimmunol. 2000 Jul 24;107(2):220-5. doi: 10.1016/s0165-5728(00)00221-6. J Neuroimmunol. 2000. PMID: 10854660
-
The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.Hum Immunol. 2015 May;76(5):385-91. doi: 10.1016/j.humimm.2014.09.021. Epub 2014 Oct 8. Hum Immunol. 2015. PMID: 25305457 Review.
-
The biology of human natural killer cells.Ann Ist Super Sanita. 1990;26(3-4):335-48. Ann Ist Super Sanita. 1990. PMID: 2091502 Review.
Cited by
-
DNA-histone complexes as ligands amplify cell penetration and nuclear targeting of anti-DNA antibodies via energy-independent mechanisms.Immunology. 2016 Jan;147(1):73-81. doi: 10.1111/imm.12542. Epub 2015 Nov 24. Immunology. 2016. PMID: 26447818 Free PMC article.
-
Fragment size analysis of free fetal DNA in maternal plasma using Y-STR loci and SRY gene amplification.Nagoya J Med Sci. 2011 Aug;73(3-4):129-35. Nagoya J Med Sci. 2011. PMID: 21928694 Free PMC article.
-
Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice.Mol Pharm. 2009 Jan-Feb;6(1):246-54. doi: 10.1021/mp8001528. Mol Pharm. 2009. PMID: 19049322 Free PMC article.
-
Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance.BMC Cancer. 2005 Jun 27;5:65. doi: 10.1186/1471-2407-5-65. BMC Cancer. 2005. PMID: 15982417 Free PMC article.
-
Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint monoclonal antibody therapies.Front Immunol. 2024 Jan 22;15:1343020. doi: 10.3389/fimmu.2024.1343020. eCollection 2024. Front Immunol. 2024. PMID: 38318190 Free PMC article. Review.
References
-
- Bell DA, Morrison B. The spontaneous apoptotic cell death of normal human lymphocytes in vitro: the release of, and immunoproliferative response to, nucleosomes in vitro. Clin Immunol Immunopathol. 1991;60:13. - PubMed
-
- Blaszezyk M, Majewski S, Wasik M, Chorzelski T, Jablonska S. Natural killer cell activity of peripheral blood mononuclear cells from patients with various forms of lupus erythematosus. Br J Dermatol. 1987;117:709. - PubMed
-
- Dunlap NE, Lane VG, Cloud GA, Tilden AB. In vitro natural killer and lymphokine-activated killer activity in patients with bronchogenic carcinoma. Cancer. 1990;66:1499. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials